Page last updated: 2024-11-05

nikethamide and Brugada Syndrome

nikethamide has been researched along with Brugada Syndrome in 1 studies

Nikethamide: A central nervous system stimulant. It was formerly used in the treatment of barbiturate overdose but is now considered to be of no value for such purposes and may be dangerous. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1229)

Brugada Syndrome: An autosomal dominant defect of cardiac conduction that is characterized by an abnormal ST-segment in leads V1-V3 on the ELECTROCARDIOGRAM resembling a right BUNDLE-BRANCH BLOCK; high risk of VENTRICULAR TACHYCARDIA; or VENTRICULAR FIBRILLATION; SYNCOPAL EPISODE; and possible sudden death. This syndrome is linked to mutations of gene encoding the cardiac SODIUM CHANNEL alpha subunit.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
LESIUIS, Ie1

Other Studies

1 other study available for nikethamide and Brugada Syndrome

ArticleYear
[Acute disorders of the ventricular rhythm of the heart as terminal disorders and some possibilities for their treatment].
    Terapevticheskii arkhiv, 1962, Volume: 34

    Topics: Arrhythmias, Cardiac; Brugada Syndrome; Camphor; Cardiac Conduction System Disease; Coronary Disease

1962